Evidence map›Paper›PMID 40331159›Full record

ArticleJournal of inflammation research2025

Mast Cells Promote Inflammatory Th17 Cells and Impair Treg Cells Through an IL-1β and PGE

Edouard Leveque, Régis Joulia, Louise Battut, Camille Laurent, Salvatore Valitutti, Nicolas Cénac, Gilles Dietrich, Eric Espinosa

Abstract read
In one paragraph

Article in Journal of inflammation research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Mast Cells in the Developing Brain.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2026
    Review
  2. Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Edouard LevequeCentre de Recherche en Cancérologie de Toulouse (CRCT), INSERM UMR1037, CNRS UMR5071, Toulouse, F-31000, France.
Régis JouliaNational Heart and Lung Institute, Imperial College London, London, SW7 2AZ, UK.
Louise BattutUniversité Toulouse III Paul Sabatier, Toulouse, F-31062, France.ORCID 0000-0001-6466-8462
Camille LaurentCentre de Recherche en Cancérologie de Toulouse (CRCT), INSERM UMR1037, CNRS UMR5071, Toulouse, F-31000, France.
Salvatore ValituttiCentre de Recherche en Cancérologie de Toulouse (CRCT), INSERM UMR1037, CNRS UMR5071, Toulouse, F-31000, France.
Nicolas CénacUniversité Toulouse III Paul Sabatier, Toulouse, F-31062, France.ORCID 0000-0002-1552-7812
Gilles DietrichUniversité Toulouse III Paul Sabatier, Toulouse, F-31062, France.ORCID 0000-0002-2232-1716
Eric EspinosaUniversité Toulouse III Paul Sabatier, Toulouse, F-31062, France.ORCID 0000-0002-3512-0921

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: CD4 Methods: This study examined human MC-Teff interactions, focusing on how MCs shape Teff responses. Flow cytometry, qRT-PCR, and cytokine assays were used to analyze the impact of primary human MCs on the Teff phenotype and function. MC-Teff crosstalk within Crohn's disease patient tissues was assessed using confocal microscopy and advanced image analysis. Results: MCs promoted the differentiation of Th17 cells, particularly the inflammatory Th17.1 subset, that secretes IFN-γ and GM-CSF. This differentiation was driven by the PGE Conclusion: MCs influence CD4

Indexed as

Crohn diseasehelper T cellsIFN-γIL-17IL-1βinflammatory Th17.1 cellsmast cellsprostaglandin E2Th17

Identifiers

PMID40331159
PMCPMC12050418

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.